why choose us

First received: January 30, 2023

Clinical Trial: Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Scoliosis Correction
Postoperative Analgesia
Esketamine
Dexmedetomidine
Chronic

Study Type: Interventional


Official Title: Effect of Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia on Long-term Outcomes Following Scoliosis Correction Surgery: 2-year Follow-up of a Randomized Controlled Trial

Brief Summary: Chronic postsurgical pain (CPSP) refers to pain that occurs or increases after surgery and lasts longer than 3 months. Severe postoperative acute pain is one of the major risk factors of CPSP. Spine surgery brings severe postoperative pain due to large trauma and long duration. Ketamine and esketamine are N-methyl-D-aspartate receptor antagonists; they have anti-hyperalgesic effects and may reduce CPSP. Dexmedetomidine is an alpha 2-adrenoceptor agonist with sedative, anxiolytic, and analgesic effect; it is…

Read more